Pub Date : 2024-09-07DOI: 10.1136/bmjinnov-2024-001234
Aimee Rowe, Matthew A Ellison, Karamveer Narang, Alex Saunders, Steve Furnell, Jagtar Dhanda
#### WHAT ARE THE NEW FINDINGS #### HOW MIGHT THIS IMPACT HEALTHCARE IN THE FUTURE Virtual reality (VR) is a promising modality for healthcare education with ample qualitative evaluation.1–3 There is meagre quantitative study of using VR in healthcare training. This study aims to gain quantitative and qualitative insights into the fidelity and validity of cardiopulmonary resuscitation (CPR) training using VR. Good quality, timely chest compressions improve survival outcomes in cardiac arrest.4–6 Traditionally, chest compressions are taught to healthcare professionals (HCPs) as part of resuscitation training using manikin-based simulation.4 Resuscitation bodies, such as The European Resuscitation Council and Resuscitation Council UK, certify trainers to deliver CPR training using scenario-based simulation with manikins. Delivering this training has logistical barriers; accessing space, equipment, staff and time to conduct training. E-learning has been widely adopted in healthcare education, helping to reduce the logistical burden of providing mandatory training to the healthcare workforce.7 Emerging technology such as VR is appealing as it has the flexibility associated with e-learning while offering a more immersive experience,8 along with the potential to increase global accessibility and reduce the environmental impact of in-person training. Novel approaches must be assessed for efficacy before committing resources to their implementation. While there are data exploring VR use for CPR training,9–11 there …
{"title":"Biomechanical analysis of delivering chest compressions in virtual reality simulation: preliminary insights into fidelity and validity of virtual reality as a means of delivering life support training","authors":"Aimee Rowe, Matthew A Ellison, Karamveer Narang, Alex Saunders, Steve Furnell, Jagtar Dhanda","doi":"10.1136/bmjinnov-2024-001234","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001234","url":null,"abstract":"#### WHAT ARE THE NEW FINDINGS #### HOW MIGHT THIS IMPACT HEALTHCARE IN THE FUTURE Virtual reality (VR) is a promising modality for healthcare education with ample qualitative evaluation.1–3 There is meagre quantitative study of using VR in healthcare training. This study aims to gain quantitative and qualitative insights into the fidelity and validity of cardiopulmonary resuscitation (CPR) training using VR. Good quality, timely chest compressions improve survival outcomes in cardiac arrest.4–6 Traditionally, chest compressions are taught to healthcare professionals (HCPs) as part of resuscitation training using manikin-based simulation.4 Resuscitation bodies, such as The European Resuscitation Council and Resuscitation Council UK, certify trainers to deliver CPR training using scenario-based simulation with manikins. Delivering this training has logistical barriers; accessing space, equipment, staff and time to conduct training. E-learning has been widely adopted in healthcare education, helping to reduce the logistical burden of providing mandatory training to the healthcare workforce.7 Emerging technology such as VR is appealing as it has the flexibility associated with e-learning while offering a more immersive experience,8 along with the potential to increase global accessibility and reduce the environmental impact of in-person training. Novel approaches must be assessed for efficacy before committing resources to their implementation. While there are data exploring VR use for CPR training,9–11 there …","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142190543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-30DOI: 10.1136/bmjinnov-2024-001248
Ahmed Nader Elgharably, Kiran Desai, Alan Michael Nevill, Aaron Vance, Jon Lester, Emma Bonfiglio, Colin Rigby, Andrew Forrester, Peter Ogrodnik, Jeffrey Faint, Tom Clutton-Brock, Aditi Desai
### WHAT ARE THE NEW FINDINGS #### HOW MIGHT IT IMPACT ON HEALTHCARE IN THE FUTURE Although uncommon, unintentionally retained surgical items remain a persistent and poorly understood medical error with the potential to cause significant harm. They are termed patient safety ‘never events’ and are considered unacceptable and largely preventable.1 The most commonly retained surgical item is the surgical swab, also known as ‘sponge’ in the USA, with the highest rates of swab retention found in the maternity setting. The UK never events database identifies vaginal swabs (used during perineal trauma repair) as the source of the largest number of swab retention events.2 3 NHS England data identifies 338 separate incidents of vaginal swab retention between 2012 and 2022 with evidence of global under-reporting due to the significant reputational impacts of these incidents as well as the difficulty in diagnosis and identification of error.1 3–6 This long-standing problem, also called ‘Gossypiboma’, was first reported in 1884 by the American Obstetrician and Gynaecologist Dr Wilson. …
{"title":"iCount: a human-factors engineered solution to vaginal swab retention – an early-stage innovation report","authors":"Ahmed Nader Elgharably, Kiran Desai, Alan Michael Nevill, Aaron Vance, Jon Lester, Emma Bonfiglio, Colin Rigby, Andrew Forrester, Peter Ogrodnik, Jeffrey Faint, Tom Clutton-Brock, Aditi Desai","doi":"10.1136/bmjinnov-2024-001248","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001248","url":null,"abstract":"### WHAT ARE THE NEW FINDINGS #### HOW MIGHT IT IMPACT ON HEALTHCARE IN THE FUTURE Although uncommon, unintentionally retained surgical items remain a persistent and poorly understood medical error with the potential to cause significant harm. They are termed patient safety ‘never events’ and are considered unacceptable and largely preventable.1 The most commonly retained surgical item is the surgical swab, also known as ‘sponge’ in the USA, with the highest rates of swab retention found in the maternity setting. The UK never events database identifies vaginal swabs (used during perineal trauma repair) as the source of the largest number of swab retention events.2 3 NHS England data identifies 338 separate incidents of vaginal swab retention between 2012 and 2022 with evidence of global under-reporting due to the significant reputational impacts of these incidents as well as the difficulty in diagnosis and identification of error.1 3–6 This long-standing problem, also called ‘Gossypiboma’, was first reported in 1884 by the American Obstetrician and Gynaecologist Dr Wilson. …","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"62 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142190544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-29DOI: 10.1136/bmjinnov-2024-001251
Helen Bevan, Diane Ketley, Roseanna Cawthorne, Charitini Stavropoulou, Harry Scarbrough
In this paper, we make a distinction between spreading and scaling innovations and spreading and scaling good practices for improvement, as many healthcare change practitioners often feel there is a “muddle” between them. We argue there are multiple factors where the spread and scale factors are similar for innovation and improvement, such as enabling leadership, the capacity and capability for spread and scale, a process of behaviour change, use of data and evidence and system alignment. However, there are multiple characteristics that may be different, including the level of complexity, the nature of the intervention, the approach to fidelity and adaptability, the source of the innovation or improvement and the outcome metrics. These insights enable us to be better equipped to design and deliver successful spread and scale strategies tailored to the specific intervention and situation and realise the full benefits of our change initiatives.
{"title":"Spreading and scaling innovation and improvement: understanding why the differences matter","authors":"Helen Bevan, Diane Ketley, Roseanna Cawthorne, Charitini Stavropoulou, Harry Scarbrough","doi":"10.1136/bmjinnov-2024-001251","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001251","url":null,"abstract":"In this paper, we make a distinction between spreading and scaling innovations and spreading and scaling good practices for improvement, as many healthcare change practitioners often feel there is a “muddle” between them. We argue there are multiple factors where the spread and scale factors are similar for innovation and improvement, such as enabling leadership, the capacity and capability for spread and scale, a process of behaviour change, use of data and evidence and system alignment. However, there are multiple characteristics that may be different, including the level of complexity, the nature of the intervention, the approach to fidelity and adaptability, the source of the innovation or improvement and the outcome metrics. These insights enable us to be better equipped to design and deliver successful spread and scale strategies tailored to the specific intervention and situation and realise the full benefits of our change initiatives.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"75 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141862813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-15DOI: 10.1136/bmjinnov-2023-001141
Cláudia Campos, Robbin Kappelhof, Joana Carrilho, Luis Midão, Diogo Henriques, Elísio Costa
Introduction Twinnings are cross-border knowledge exchange activities where two or more organisations learn from each other’s experiences and are often used as a scaling up mechanism. Objectives This paper discusses the importance of twinning activities in scaling up by promoting community building, knowledge sharing and innovation transfer among stakeholders in European countries. It explores the role of twinnings in the scaling up model of the European Innovation Partnership on Active and Healthy Ageing) and the Innovation Networks for Scaling Active and Healthy Ageing (IN-4-AHA) project. Methods The study employed a qualitative approach, drawing insights from various sources, including the Scale AHA study (2017), the IN-4-AHA’s scaling up model and twinning reports. Results The findings reveal that twinning activities provide stakeholders with a unique opportunity to learn from the know-how of other like-minded partners, improve the quality of their work and iterate on their innovations. They also highlight that twinnings are particularly relevant for some stages in the scaling up process, such as in the assessment of a network of potential partners and during the evaluation of the environment, the innovation could potentially be transferred to. Conclusion Twinnings are highly regarded as community-building and knowledge-sharing activities with clear advantages for companies and other stakeholder groups. Including twinning activities in the scaling up model has proven benefits for companies and projects that have a strong need for community building and innovation transfer. Data sharing not applicable as no data sets generated and/or analysed for this study.
引言 结对活动是两个或两个以上组织相互学习经验的跨境知识交流活动，通常被用作扩大规模的机制。目的 本文讨论了结对活动通过促进欧洲国家利益相关者之间的社区建设、知识共享和创新转让在扩大规模方面的重要性。本文探讨了结对活动在 "欧洲老有所事和健康老龄化创新伙伴关系"（European Innovation Partnership on Active and Healthy Ageing）和 "加强老有所事和健康老龄化创新网络"（IN-4-AHA）项目的推广模式中的作用。方法 本研究采用定性方法，从各种来源汲取见解，包括 "Scale AHA 研究"（2017 年）、IN-4-AHA 的推广模式和结对报告。结果 研究结果表明，结对活动为利益相关者提供了一个独特的机会，使他们能够学习其他志同道合的合作伙伴的专门技能，提高工作质量，并对创新进行迭代。调查结果还强调，结对活动与扩大规模过程中的某些阶段特别相关，例如在评估潜在合作伙伴网络和评估创新可能转移到的环境期间。结论 结对活动被视为社区建设和知识共享活动，对企业和其他利益相关群体具有明显的优势。事实证明，将结对活动纳入扩大规模模式，对那些非常需要社区建设和创新转让的公司和项目大有裨益。数据共享不适用，因为本研究没有生成和/或分析数据集。
{"title":"Role of twinnings in scaling up innovative solutions across Europe","authors":"Cláudia Campos, Robbin Kappelhof, Joana Carrilho, Luis Midão, Diogo Henriques, Elísio Costa","doi":"10.1136/bmjinnov-2023-001141","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001141","url":null,"abstract":"Introduction Twinnings are cross-border knowledge exchange activities where two or more organisations learn from each other’s experiences and are often used as a scaling up mechanism. Objectives This paper discusses the importance of twinning activities in scaling up by promoting community building, knowledge sharing and innovation transfer among stakeholders in European countries. It explores the role of twinnings in the scaling up model of the European Innovation Partnership on Active and Healthy Ageing) and the Innovation Networks for Scaling Active and Healthy Ageing (IN-4-AHA) project. Methods The study employed a qualitative approach, drawing insights from various sources, including the Scale AHA study (2017), the IN-4-AHA’s scaling up model and twinning reports. Results The findings reveal that twinning activities provide stakeholders with a unique opportunity to learn from the know-how of other like-minded partners, improve the quality of their work and iterate on their innovations. They also highlight that twinnings are particularly relevant for some stages in the scaling up process, such as in the assessment of a network of potential partners and during the evaluation of the environment, the innovation could potentially be transferred to. Conclusion Twinnings are highly regarded as community-building and knowledge-sharing activities with clear advantages for companies and other stakeholder groups. Including twinning activities in the scaling up model has proven benefits for companies and projects that have a strong need for community building and innovation transfer. Data sharing not applicable as no data sets generated and/or analysed for this study.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"1 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140156795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The healthcare sector is among the most rapidly expanding sectors. Drones are increasingly being used to reach the unreached in healthcare. Drones exhibit profound significance by overcoming accessibility challenges and offering versatile solutions. The future of healthcare is in the air, and new government initiatives uncover the country’s rapid market growth. Investments in drone technologies are rising, with research predicting significant drone expansion in the upcoming decade. Since this sector is still in its nascent stage, the time is ripe for stakeholders to collectively work for the effective implementation of drone technology in India. In this context, the paper seeks to bridge existing knowledge gaps by analysing the global regulatory landscape, the evolution of drones in India, used cases in healthcare, and the barriers that constrain their deployment in the healthcare domain. It explores the obstacles that hinder the widespread adoption of drones. Addressing these challenges becomes essential in unlocking the full potential of drone technology in revolutionising healthcare delivery, enhancing patient outcomes and overcoming logistical constraints. The report argues about the potential shift drones can bring to healthcare delivery while underlining the necessity of addressing regulatory concerns and fostering public trust.
{"title":"Wings of Healing: regulatory landscape, case studies and the Indian prologue of drones in healthcare","authors":"Ankita Sharma, Anju Vijayan, Pavan Ananth, Deepshikha Chhetri, Rahul Konapur, Nachiket Gudi","doi":"10.1136/bmjinnov-2023-001179","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001179","url":null,"abstract":"The healthcare sector is among the most rapidly expanding sectors. Drones are increasingly being used to reach the unreached in healthcare. Drones exhibit profound significance by overcoming accessibility challenges and offering versatile solutions. The future of healthcare is in the air, and new government initiatives uncover the country’s rapid market growth. Investments in drone technologies are rising, with research predicting significant drone expansion in the upcoming decade. Since this sector is still in its nascent stage, the time is ripe for stakeholders to collectively work for the effective implementation of drone technology in India. In this context, the paper seeks to bridge existing knowledge gaps by analysing the global regulatory landscape, the evolution of drones in India, used cases in healthcare, and the barriers that constrain their deployment in the healthcare domain. It explores the obstacles that hinder the widespread adoption of drones. Addressing these challenges becomes essential in unlocking the full potential of drone technology in revolutionising healthcare delivery, enhancing patient outcomes and overcoming logistical constraints. The report argues about the potential shift drones can bring to healthcare delivery while underlining the necessity of addressing regulatory concerns and fostering public trust.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"271 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140045281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1136/bmjinnov-2023-001110
Max Rollwage, Johanna Habicht, Keno Juchems, Ben Carrington, Tobias U Hauser, Ross Harper
Mental health services across the globe are overburdened due to increased patient need for psychological therapies and a shortage of qualified mental health practitioners. This is unlikely to change in the short-to-medium term. Digital support is urgently needed to facilitate access to mental healthcare while creating efficiencies in service delivery. In this paper, we evaluate the use of a conversational artificial intelligence (AI) solution ( Limbic Access ) to assist both patients and mental health practitioners with referral, triage, and clinical assessment of mild-to-moderate adult mental illness. Assessing this solution in the context of England’s National Health Service (NHS) Talking Therapies services, we demonstrate in a cohort study design that deploying such an AI solution is associated with improved recovery rates. We find that those NHS Talking Therapies services that introduced the conversational AI solution improved their recovery rates, while comparable NHS Talking Therapies services across the country reported deteriorating recovery rates during the same time period. Further, we provide an economic analysis indicating that the usage of this AI solution can be highly cost-effective relative to other methods of improving recovery rates. Together, these results highlight the potential of AI solutions to support mental health services in the delivery of quality care in the context of worsening workforce supply and system overburdening. For transparency, the authors of this paper declare our conflict of interest as employees and shareholders of Limbic Access, the AI solution referred to in this paper. Data available at a dedicated GitHub repository. Code and data supporting this study are available at a dedicated GitHub repository.
{"title":"Conversational AI facilitates mental health assessments and is associated with improved recovery rates","authors":"Max Rollwage, Johanna Habicht, Keno Juchems, Ben Carrington, Tobias U Hauser, Ross Harper","doi":"10.1136/bmjinnov-2023-001110","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001110","url":null,"abstract":"Mental health services across the globe are overburdened due to increased patient need for psychological therapies and a shortage of qualified mental health practitioners. This is unlikely to change in the short-to-medium term. Digital support is urgently needed to facilitate access to mental healthcare while creating efficiencies in service delivery. In this paper, we evaluate the use of a conversational artificial intelligence (AI) solution ( Limbic Access ) to assist both patients and mental health practitioners with referral, triage, and clinical assessment of mild-to-moderate adult mental illness. Assessing this solution in the context of England’s National Health Service (NHS) Talking Therapies services, we demonstrate in a cohort study design that deploying such an AI solution is associated with improved recovery rates. We find that those NHS Talking Therapies services that introduced the conversational AI solution improved their recovery rates, while comparable NHS Talking Therapies services across the country reported deteriorating recovery rates during the same time period. Further, we provide an economic analysis indicating that the usage of this AI solution can be highly cost-effective relative to other methods of improving recovery rates. Together, these results highlight the potential of AI solutions to support mental health services in the delivery of quality care in the context of worsening workforce supply and system overburdening. For transparency, the authors of this paper declare our conflict of interest as employees and shareholders of Limbic Access, the AI solution referred to in this paper. Data available at a dedicated GitHub repository. Code and data supporting this study are available at a dedicated GitHub repository.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"72 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140018774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-10DOI: 10.1136/bmjinnov-2023-001097
Caoimhe Madden, Róisín O'Malley, Emily O'Dowd, Paul O'Connor, Sinéad Lydon, Jared Gormly, Dara Byrne
Objective The lack of quantitative evidence of effectiveness has been cited as a notable shortcoming of initiation and diffusion of innovations in healthcare. Therefore, this review aimed to synthesise research assessing the impact of healthcare innovations on measurable outcomes of healthcare organisation performance. Design A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources Systematic searches were conducted across three electronic databases, namely MEDLINE, CINAHL and PsycINFO. Eligibility criteria for selecting studies Articles were required to: (a) be published in an English-language, peer-reviewed journal since 2000; (b) describe the application of a specific innovation within a secondary healthcare setting; (c) report data on the summative evaluation of the impact of the innovation on healthcare outcomes, using an outcome measure in line with Level Four of Kirkpatrick’s Evaluation Hierarchy (ie, a measure of organisation performance) and (d) consist of a research design that allowed for evaluation of innovation impact on outcome measures by means of a comparator. Results Innovations targeting organisational change were most commonly implemented. Innovations generally had a positive impact, evident in almost two-thirds of the outcome measures assessed across the included articles. Innovation impact was predominantly measured via health utilisation metrics and medical-clinical indicators, with safety outcomes and patient/family perceptions less frequently assessed. Conclusion There is evidence to show that innovations result in discernible change in organisational importance, including on important metrics such as finance and healthcare utilisation. Bundling outcome measures are recommended to provide a more complete picture of the true impact of innovation on healthcare organisation performance. Data are available on reasonable request.
{"title":"What is the impact of healthcare innovation on measurable outcomes of healthcare organisation performance? A systematic review","authors":"Caoimhe Madden, Róisín O'Malley, Emily O'Dowd, Paul O'Connor, Sinéad Lydon, Jared Gormly, Dara Byrne","doi":"10.1136/bmjinnov-2023-001097","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001097","url":null,"abstract":"Objective The lack of quantitative evidence of effectiveness has been cited as a notable shortcoming of initiation and diffusion of innovations in healthcare. Therefore, this review aimed to synthesise research assessing the impact of healthcare innovations on measurable outcomes of healthcare organisation performance. Design A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources Systematic searches were conducted across three electronic databases, namely MEDLINE, CINAHL and PsycINFO. Eligibility criteria for selecting studies Articles were required to: (a) be published in an English-language, peer-reviewed journal since 2000; (b) describe the application of a specific innovation within a secondary healthcare setting; (c) report data on the summative evaluation of the impact of the innovation on healthcare outcomes, using an outcome measure in line with Level Four of Kirkpatrick’s Evaluation Hierarchy (ie, a measure of organisation performance) and (d) consist of a research design that allowed for evaluation of innovation impact on outcome measures by means of a comparator. Results Innovations targeting organisational change were most commonly implemented. Innovations generally had a positive impact, evident in almost two-thirds of the outcome measures assessed across the included articles. Innovation impact was predominantly measured via health utilisation metrics and medical-clinical indicators, with safety outcomes and patient/family perceptions less frequently assessed. Conclusion There is evidence to show that innovations result in discernible change in organisational importance, including on important metrics such as finance and healthcare utilisation. Bundling outcome measures are recommended to provide a more complete picture of the true impact of innovation on healthcare organisation performance. Data are available on reasonable request.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"12 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139420807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-10DOI: 10.1136/bmjinnov-2023-001122
S K Mohanasundari, Sivam Thanigainathan, R Gadapalli, Pankaj Rawat, S Vandana, K Deepak, N Gupta
Introduction Although nasopharyngeal/oropharyngeal swabs are considered the gold standard for SARS-CoV-2 diagnosis, these procedures are distressing, require trained personnel and may pose a risk of transmission. Aim This study aims to assess the functional capacity, safety, ability to isolate the novel COVID-19 and end-users’ acceptance of a novel self-collection device for obtaining nasopharyngeal wash samples. Methods Initially, the novel device’s functional capacity (amount of nasopharyngeal wash specimen collected by participants themselves using the novel device) and safety (procedure-related complications such as bleeding, aspiration or syncope) were assessed in 15 healthy volunteers. Then, its ability to isolate the novel COVID-19 in symptomatic patients, procedure-related discomfort and end-users’ acceptance were compared with the conventional nasopharyngeal/oropharyngeal swab technique. Results All 15 volunteers obtained more than 1 mL of nasopharyngeal wash sample using the novel device, with no reported medical complications. Out of 14 COVID-19-suspected patients, 9 tested positive using the novel method compared with 8 with the conventional method (p=0.09). The novel method demonstrated significantly less discomfort (median score 1 vs 5, p<0.001) and significantly higher acceptability (median score 9 vs 2, p<0.001) compared with the conventional method. Conclusion The novel self-administrative nasopharyngeal wash specimen-collecting device allowed patients to collect samples safely. The procedure could isolate the novel COVID-19 from the nasopharynx, similar to the conventional nasopharyngeal swab technique. The novel method was less discomforting and more acceptable for end-users compared with the conventional method and is suitable for mass screening.
{"title":"Exploratory study to assess the functional capacity, safety and ability to isolate novel COVID-19 of a novel self-administrative nasopharyngeal wash specimen collecting device","authors":"S K Mohanasundari, Sivam Thanigainathan, R Gadapalli, Pankaj Rawat, S Vandana, K Deepak, N Gupta","doi":"10.1136/bmjinnov-2023-001122","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001122","url":null,"abstract":"Introduction Although nasopharyngeal/oropharyngeal swabs are considered the gold standard for SARS-CoV-2 diagnosis, these procedures are distressing, require trained personnel and may pose a risk of transmission. Aim This study aims to assess the functional capacity, safety, ability to isolate the novel COVID-19 and end-users’ acceptance of a novel self-collection device for obtaining nasopharyngeal wash samples. Methods Initially, the novel device’s functional capacity (amount of nasopharyngeal wash specimen collected by participants themselves using the novel device) and safety (procedure-related complications such as bleeding, aspiration or syncope) were assessed in 15 healthy volunteers. Then, its ability to isolate the novel COVID-19 in symptomatic patients, procedure-related discomfort and end-users’ acceptance were compared with the conventional nasopharyngeal/oropharyngeal swab technique. Results All 15 volunteers obtained more than 1 mL of nasopharyngeal wash sample using the novel device, with no reported medical complications. Out of 14 COVID-19-suspected patients, 9 tested positive using the novel method compared with 8 with the conventional method (p=0.09). The novel method demonstrated significantly less discomfort (median score 1 vs 5, p<0.001) and significantly higher acceptability (median score 9 vs 2, p<0.001) compared with the conventional method. Conclusion The novel self-administrative nasopharyngeal wash specimen-collecting device allowed patients to collect samples safely. The procedure could isolate the novel COVID-19 from the nasopharynx, similar to the conventional nasopharyngeal swab technique. The novel method was less discomforting and more acceptable for end-users compared with the conventional method and is suitable for mass screening.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"86 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139423537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-07DOI: 10.1136/bmjinnov-2023-001083
Jill Thompson, Dylan Yamada-Rice, Sean Thompson, Louise Murray, Matthew Taylor
{"title":"Development and introduction of a mixed realities playkit: decreasing the incidence of general anaesthesia for paediatric MRI","authors":"Jill Thompson, Dylan Yamada-Rice, Sean Thompson, Louise Murray, Matthew Taylor","doi":"10.1136/bmjinnov-2023-001083","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001083","url":null,"abstract":"","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"21 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135539924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-25DOI: 10.1136/bmjinnov-2023-001188
Chris Zielinski
{"title":"Time to treat the climate and nature crisis as one indivisible global health emergency","authors":"Chris Zielinski","doi":"10.1136/bmjinnov-2023-001188","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001188","url":null,"abstract":"","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"2 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135217163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：